Running down the patent market’s finest in this year’s top 40 market markers
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
@IAM_Alerts Thousands of existing pharma and medical device patents to have terms shortened, decides Brazilian Supreme Court:… https://t.co/bvvKQcnddx Read more
@IAM_Alerts A must read for patent licensors in China - exclusive analysis of a Ningbo court's recent antitrust ruling against… https://t.co/N2nTKOQpa5 Read more
@IAM_Alerts The Long Read: Nokia-Daimler SEP licensing stand-off shows why auto supplier indemnification is crucial… https://t.co/oNpJqJHiFF Read more
@IAM_Alerts Australian biotech IP owners look set to get a long-sought win as government unveils patent box scheme in latest bu… https://t.co/jbexNlMoi5 Read more